Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2011-04-27

Clinical Trial Update: Dose Response of Mirtazapine to Methamphetamine Induced Interest, Mood Elevation and Reward [NA]

View source ↗

Summary

This entry notes that a clinical trial evaluating the effect of mirtazapine on methamphetamine-induced interest, mood elevation, and reward was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

Sponsor: University of Virginia | Conditions: Amphetamine Dependence | NA | Status: WITHDRAWN